Thank you for your interest in this study. The purpose of this research is to understand the experiences of individuals living with wet age-related macular degeneration (wet AMD) or diabetic macular edema (DME) who are being treated with EYLEA HD®. We will be asking you some questions to see if you are eligible to participate. Individuals who meet the eligibility criteria may then be asked to take part in a 60-minute telephone interview.
Your answers to these questions will be treated as confidential. They will be stored in an access-controlled file and kept secure at all times. Personally identifiable information, such as names and locations, will be removed and your information will not be passed on to any other organization without your permission. Your identifiable data will be destroyed five years after completion of study, and anonymized data will be retained for up to fifteen (15) years.
If you are eligible to take part in the interview based on your responses to these questions, you will be provided with a consent form, which explains how the study works and your rights as a study participant. You can then decide, based on the consent form information, whether you would like to take part or not.
This research is being conducted by IQVIA™ on behalf of the study Sponsor, a biopharmaceutical company. You have the right to withdraw at any time. For more information about your rights, please see our privacy notice, which is available at
www.iqvia.com/about-us/privacy.
If you have any questions, please contact the study team at
EyeInterviews@iqvia.com.